Ранолазин и ЧКВ (чрезкожное коронарное вмешательство) - Идеальное партнерство скачать в хорошем качестве

Ранолазин и ЧКВ (чрезкожное коронарное вмешательство) - Идеальное партнерство

1. Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pec-toris of the European Society of Cardiology. Eur Heart J 2006; 27: 1341-1381. 2. Ischemic Heart Disease. New York: Churchill Livingstone Inc., 1995. 3. Coronary microvascular dys-function. N Engl J Med 2007; 356: 830-840. 4. Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation 2010; 121: 2317-2325. 5. Coronary artery spasm: a 2009 update. Circulation 2009; 119: 2531-2534. 6. Nonatherosclerotic Ischemic Heart Disease. New York: Raven Press, 1988. 7. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med 1994; 330: 1782-1788. 8. Coronary blood flow and myocardial ischemia. In Fuster V, Alexander RW, O’Rourke RA. Hurst’s The Heart. New York: McGraw-Hill, 2004, pp. 1153-1172. 9. Diagnosis and treatment of coronary artery spasm. Cardiol Rev 1996; 1: 1-6. 10. Local coronary supersensi-tivity to diverse vasoconstrictive stimuli in patients with variant angina. Circulation 1986; 74: 1255-1265. 11. Autonomic changes associated with spon-taneous coronary spasm in patients with variant angina. J Am Coll Cardiol 1996; 28: 1249-1256. 12. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation 2002; 105: 1545-1547. 13. Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels. J Clin In-vest 2002; 110: 203-208. 14. Low incidence of serotonin-induced occlusive coronary artery spasm in patients with recent my-ocardial infarction. Am J Cardiol 1996; 78: 84-87. 15. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-seg-ment elevation: The Task Force for the manage-ment of acute coronary syndromes (ACS) in pa-tients presenting without persistent ST-segment ele-vation of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 2999-3054. 16. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007; 356: 2388-2398. 17. Prevalence and correlates of angi-na pectoris in the Italian nine communities study. Re-search Group ATS-RF2 of the Italian National Re-search Council. Epidemiology 1991; 2: 26-32. 18. Prevalence of non-fatal coronary heart disease among American adults. Am Heart J 2000; 139: 371-377. 19. Us-ing the WHO (Rose) angina questionnaire in car-diovascular epidemiology. Int J Epidemiol 1989; 18: 607-613. 20. Myocardial ischemia caused by dis-tal coronary artery constriction in stable angina pec-toris. N Engl J Med 1990; 323: 514-520. 21. Grading of angina pectoris. Circulaton 1976; 54: 522-523. 22. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status In-dex). Am J Cardiol 1989; 64: 651-654. 23. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol 1995; 25: 333-341. 24. Health status predicts long-term outcome in out-patients with coronary disease. Circulation 2002; 106: 43-49.